322 related articles for article (PubMed ID: 37568655)
1. Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects.
Chaddad A; Tan G; Liang X; Hassan L; Rathore S; Desrosiers C; Katib Y; Niazi T
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568655
[TBL] [Abstract][Full Text] [Related]
2. Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review.
Feretzakis G; Juliebø-Jones P; Tsaturyan A; Sener TE; Verykios VS; Karapiperis D; Bellos T; Katsimperis S; Angelopoulos P; Varkarakis I; Skolarikos A; Somani B; Tzelves L
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398201
[TBL] [Abstract][Full Text] [Related]
3. More than Meets the Eye: Using Textural Analysis and Artificial Intelligence as Decision Support Tools in Prostate Cancer Diagnosis-A Systematic Review.
Telecan T; Andras I; Crisan N; Giurgiu L; Căta ED; Caraiani C; Lebovici A; Boca B; Balint Z; Diosan L; Lupsor-Platon M
J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743766
[TBL] [Abstract][Full Text] [Related]
4. A dynamic-static combination model based on radiomics features for prostate cancer using multiparametric MRI.
Li S; Zheng T; Fan Z; Qu H; Wang J; Bi J; Lv Q; Zhang G; Cui X; Zhao Y
Phys Med Biol; 2022 Dec; 68(1):. PubMed ID: 36541844
[No Abstract] [Full Text] [Related]
5. Radiomics and Prostate MRI: Current Role and Future Applications.
Cutaia G; La Tona G; Comelli A; Vernuccio F; Agnello F; Gagliardo C; Salvaggio L; Quartuccio N; Sturiale L; Stefano A; Calamia M; Arnone G; Midiri M; Salvaggio G
J Imaging; 2021 Feb; 7(2):. PubMed ID: 34460633
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review.
Chaddad A; Kucharczyk MJ; Cheddad A; Clarke SE; Hassan L; Ding S; Rathore S; Zhang M; Katib Y; Bahoric B; Abikhzer G; Probst S; Niazi T
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535569
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer radiomics and the promise of radiogenomics.
Stoyanova R; Takhar M; Tschudi Y; Ford JC; Solórzano G; Erho N; Balagurunathan Y; Punnen S; Davicioni E; Gillies RJ; Pollack A
Transl Cancer Res; 2016 Aug; 5(4):432-447. PubMed ID: 29188191
[TBL] [Abstract][Full Text] [Related]
8. [Artificial intelligence and radiomics in MRI-based prostate diagnostics].
Hamm CA; Beetz NL; Savic LJ; Penzkofer T
Radiologe; 2020 Jan; 60(1):48-55. PubMed ID: 31802148
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?
Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
Eur Urol Focus; 2022 Mar; 8(2):409-417. PubMed ID: 33773964
[TBL] [Abstract][Full Text] [Related]
10. MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer.
Zhu X; Shao L; Liu Z; Liu Z; He J; Liu J; Ping H; Lu J
J Zhejiang Univ Sci B; 2023 Aug; 24(8):663-681. PubMed ID: 37551554
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI and radiomics in prostate cancer: a review.
Sun Y; Reynolds HM; Parameswaran B; Wraith D; Finnegan ME; Williams S; Haworth A
Australas Phys Eng Sci Med; 2019 Mar; 42(1):3-25. PubMed ID: 30762223
[TBL] [Abstract][Full Text] [Related]
12. Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 2: in-vivo tumor-targeting using a classification model combining spectral and MRI-radiomics features.
Grajales Lopera DO; Picot F; Shams R; Dallaire F; Sheehy G; Alley S; Barkati M; Delouya G; Carrier JF; Birlea M; Trudel D; Leblond F; Ménard C; Kadoury S
J Biomed Opt; 2022 Sep; 27(9):. PubMed ID: 36085571
[TBL] [Abstract][Full Text] [Related]
13. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
Ferro M; de Cobelli O; Vartolomei MD; Lucarelli G; Crocetto F; Barone B; Sciarra A; Del Giudice F; Muto M; Maggi M; Carrieri G; Busetto GM; Falagario U; Terracciano D; Cormio L; Musi G; Tataru OS
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576134
[TBL] [Abstract][Full Text] [Related]
15. Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study.
Faiella E; Vertulli D; Esperto F; Cordelli E; Soda P; Muraca RM; Moramarco LP; Grasso RF; Beomonte Zobel B; Santucci D
Tomography; 2022 Aug; 8(4):2010-2019. PubMed ID: 36006066
[TBL] [Abstract][Full Text] [Related]
16. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
[TBL] [Abstract][Full Text] [Related]
17. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI and Radiomics in Prostate Cancer: A Review of the Current Literature.
Midiri F; Vernuccio F; Purpura P; Alongi P; Bartolotta TV
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679527
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.
Yang F; Ford JC; Dogan N; Padgett KR; Breto AL; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Transl Androl Urol; 2018 Jun; 7(3):445-458. PubMed ID: 30050803
[TBL] [Abstract][Full Text] [Related]
20. Radiogenomics influence on the future of prostate cancer risk stratification.
Banerjee V; Wang S; Drescher M; Russell R; Siddiqui MM
Ther Adv Urol; 2022; 14():17562872221125317. PubMed ID: 36160762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
